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Objectives: The variable number tandem repeat polymorphism of the human clock 
gene PER3 is involved in circadian and homeostatic regulation of human sleep and 
wakefulness. Here we investigated subjective sleepiness and sleep during naps in 
homozygous PER3 4/4 and PER3 5/5 allele carriers under high and low sleep 
pressure conditions. The aim of this study was to further unravel associations 
between inter-individual differences in the homeostatic and circadian impact on sleep 
and wakefulness related to this polymorphism. Methods: So far, 22 healthy 
participants (25.1 ± 3.4 year), thereof 12 PER3-5/5 (5 m, 7 f) and 10 PER3-4/4 (4 m, 
6 f), underwent both a 40-h sleep deprivation (SD) and nap (NP; 10 cycles of 160-min 
wakefulness and 80-min naps) protocol. The groups were matched according to sex, 
age, BMI, sleep quality and chronotype. Subjective sleepiness was assessed at 
regular intervals during both protocols along with subjective sleep quality after each 
nap. Polysomnographic recordings during naps were scored visually according to 
standard criteria. Results: Significant effects for genotype · time (P < 0.05) and a 
trend for genotype · sleep pressure (P = 0.07) revealed higher sleepiness levels in 
PER35/5 than in PER34/4 subjects at specific times during SD and NP. PER35/5 
carries were sleepier after 9–16.5 h of scheduled wakefulness (P < 0.05) during SD, 
while during NP they differed after six naps and stated less difficulties to fall asleep in 
the subsequent nap at the rise of the second biological day (P < 0.05). Analysis of 
total sleep time, sleep efficiency, wakefulness and sleep stages over all naps did not 
reveal a main effect of genotype. Both groups slept least in the naps during biological 
evenings (wake-maintenance zone, WMZ) and most during the biological night. 
However, during the WMZ, PER35/5 carriers slept more than PER34/4 individuals, as 
indexed by a greater amount of NREM sleep (P < 0.05).  Conclusion: Our data 
suggest greater subjective susceptibility of PER35/5 than PER34/4 carriers to 
increases in homeostatic sleep pressure, emerging already after 9 h awake. In 
conjunction with the finding of more NREM sleep during the nap in the WMZ in 
PER35/5, as well as the higher sleepiness in the beginning of the second biological 
day, the data indicate that the reported differential vulnerability to sleep homeostasis 
in PER35/5 and PER34/4 carriers might be partially mediated by a difference in the 
strength of the circadian arousal signal. 
